These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 32046221)
21. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
22. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis. Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135 [TBL] [Abstract][Full Text] [Related]
23. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases. Nguyen PC; Madani A; Santucci P; Martin BP; Paudel RR; Delattre S; Herrmann JL; Spilling CD; Kremer L; Canaan S; Cavalier JF Int J Antimicrob Agents; 2018 Apr; 51(4):651-654. PubMed ID: 29241819 [TBL] [Abstract][Full Text] [Related]
24. Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds. Bianco MV; Blanco FC; Imperiale B; Forrellad MA; Rocha RV; Klepp LI; Cataldi AA; Morcillo N; Bigi F BMC Infect Dis; 2011 Jul; 11():195. PubMed ID: 21762531 [TBL] [Abstract][Full Text] [Related]
25. Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium. Machado D; Cannalire R; Santos Costa S; Manfroni G; Tabarrini O; Cecchetti V; Couto I; Viveiros M; Sabatini S ACS Infect Dis; 2015 Dec; 1(12):593-603. PubMed ID: 27623057 [TBL] [Abstract][Full Text] [Related]
26. Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis. Rodrigues L; Villellas C; Bailo R; Viveiros M; Aínsa JA Antimicrob Agents Chemother; 2013 Feb; 57(2):751-7. PubMed ID: 23165464 [TBL] [Abstract][Full Text] [Related]
27. Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates. Li G; Zhang J; Guo Q; Wei J; Jiang Y; Zhao X; Zhao LL; Liu Z; Lu J; Wan K J Antibiot (Tokyo); 2015 Jul; 68(7):431-5. PubMed ID: 25690361 [TBL] [Abstract][Full Text] [Related]
28. Antimycobacterial activities of selected medicinal plants from Zimbabwe against Mycobacterium aurum and Corynebacterium glutamicum. Chimponda T; Mukanganyama S Trop Biomed; 2010 Dec; 27(3):595-610. PubMed ID: 21399602 [TBL] [Abstract][Full Text] [Related]
29. Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria. Sen T; Neog K; Sarma S; Manna P; Deka Boruah HP; Gogoi P; Singh AK Bioorg Med Chem; 2018 Sep; 26(17):4942-4951. PubMed ID: 30190182 [TBL] [Abstract][Full Text] [Related]
35. Mycobacterial efflux pumps and chemotherapeutic implications. Viveiros M; Leandro C; Amaral L Int J Antimicrob Agents; 2003 Sep; 22(3):274-8. PubMed ID: 13678834 [TBL] [Abstract][Full Text] [Related]
36. A novel marRAB operon contributes to the rifampicin resistance in Mycobacterium smegmatis. Zhang H; Gao L; Zhang J; Li W; Yang M; Zhang H; Gao C; He ZG PLoS One; 2014; 9(8):e106016. PubMed ID: 25153492 [TBL] [Abstract][Full Text] [Related]
37. Phenylpropanoids of Alpinia galanga as efflux pump inhibitors in Mycobacterium smegmatis mc² 155. Roy SK; Pahwa S; Nandanwar H; Jachak SM Fitoterapia; 2012 Oct; 83(7):1248-55. PubMed ID: 22735598 [TBL] [Abstract][Full Text] [Related]
38. The human proton pump inhibitors inhibit Lake MA; Adams KN; Nie F; Fowler E; Verma AK; Dei S; Teodori E; Sherman DR; Edelstein PH; Spring DR; Troll M; Ramakrishnan L Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2215512120. PubMed ID: 36763530 [TBL] [Abstract][Full Text] [Related]